10-year data show no benefit when adding cetuximab to radiation and cisplatinMarch 3, 2020Head & Neck/Thyroid Cancers
‘Promising’ responses with preoperative immunotherapy in oral cavity cancerMarch 2, 2020Head & Neck/Thyroid Cancers
FDA: Cell phones still look safeFebruary 11, 2020Mixed TopicsCNS/Brain CancerBreast CancerLung CancerLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic Cancer
Global project reveals cancer’s genomic playbookFebruary 5, 2020Mixed TopicsCNS/Brain CancerBreast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersGynecologic Cancer
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Renal Cell CarcinomaImmuno-oncologyGenitourinary CancerMelanomaLung CancerGynecologic CancerHead & Neck/Thyroid Cancers
Multimodal therapies almost double survival in anaplastic thyroid cancerNovember 20, 2019Head & Neck/Thyroid Cancers
Opioid-free regimen after neck dissection keeps patients comfortableNovember 4, 2019Head & Neck/Thyroid Cancers
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapyAugust 12, 2019Lung CancerImmuno-oncologyHead & Neck/Thyroid Cancers
Ado-trastuzumab highly efficacious for rare HER2-amplified SGCsJune 2, 2019Head & Neck/Thyroid Cancers
Pembro with or without chemo superior to EXTREME for advanced HNSCCJune 1, 2019Head & Neck/Thyroid CancersImmuno-oncology
Novel anti-PD-1 antibody can be given subcutaneouslyMay 31, 2019Immuno-oncologyImmunotherapyHead & Neck/Thyroid Cancers
Study finds inconsistent links with aspirin, nonaspirin NSAIDs and reduced skin cancer riskMay 28, 2019Nonmelanoma Skin CancerPreventive CareHead & Neck/Thyroid Cancers
PET imaging at diagnosis improves oropharyngeal cancer outcomesMay 16, 2019Head & Neck/Thyroid Cancers
